Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2021

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD) has announced its participation in three upcoming virtual investor conferences. The events include the Morgan Stanley 19th Annual Global Healthcare Conference on September 10, 2021, the Bank of America Global Healthcare Conference on September 15, 2021, and the Cantor Global Healthcare Conference on September 27, 2021. Live audio webcasts for each presentation will be accessible through the Investors section of their website. Amicus focuses on developing high-quality medicines for rare metabolic diseases.

News Market Reaction – FOLD

-1.77%

-1.77% Session move

In the trading session that priced this news, FOLD declined 1.77%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PHILADELPHIA, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in upcoming presentations at the following virtual investor conferences in September:

• Morgan Stanley 19^th Annual Global Healthcare Conference on Friday, September 10, 2021 at 3:30 p.m. E.T.
• Bank of America Global Healthcare Conference 2021 on Wednesday, September 15, 2021 at 4:45 p.m. B.S.T. (11:45 a.m. E.T.)
• Cantor Global Healthcare Conference 2021 on Monday, September 27, 2021 at 8:40 a.m. E.T.
  

A live audio webcast of each presentation can be accessed via the Investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow us on Twitter and LinkedIn.

CONTACT:

Investors:
Andrew Faughnan
Executive Director, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Diana Moore
Head of Global Corporate Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G

FAQ

What is the schedule for the upcoming investor conferences for Amicus Therapeutics (FOLD)?

Amicus Therapeutics will participate in three investor conferences: Morgan Stanley on September 10, 2021, Bank of America on September 15, 2021, and Cantor on September 27, 2021.

How can I access the live webcasts for the Amicus Therapeutics (FOLD) presentations?

You can access the live audio webcasts for the presentations on the Investors section of the Amicus Therapeutics corporate website.

What is the focus of Amicus Therapeutics (FOLD) as a biotechnology company?

Amicus Therapeutics focuses on discovering and developing novel medicines for individuals with rare metabolic diseases.

When is the Cantor Global Healthcare Conference for Amicus Therapeutics (FOLD)?

The Cantor Global Healthcare Conference for Amicus Therapeutics is scheduled for September 27, 2021, at 8:40 a.m. E.T.

What time will Amicus Therapeutics (FOLD) present at the Bank of America Global Healthcare Conference?

Amicus Therapeutics will present at the Bank of America Global Healthcare Conference on September 15, 2021, at 4:45 p.m. B.S.T. (11:45 a.m. E.T.).